Rising Tide
Rising Tide is a Venture Capital Firm.
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Rising Tide.
Rising Tide is a Venture Capital Firm.
Key people at Rising Tide.
Rising Tide is a Silicon Valley-based venture capital firm founded in 2007 that operates as an early-stage investor with a distinctive focus on overlooked founders and underserved markets.[1][4] The firm's mission centers on identifying and backing visionary entrepreneurs who operate outside mainstream venture capital circles, leveraging research showing that overlooked co-founder teams deliver 30% higher returns than conventional counterparts.[1] Rather than viewing unconventional founders as higher risk, Rising Tide sees untapped potential in founders and markets that traditional investors overlook.
The firm's investment philosophy emphasizes more than capital deployment—it provides hands-on mentorship, talent connections, and strategic partnerships to help founders scale their visions.[1] Rising Tide maintains a geographically diverse presence with roots spanning the US, Canada, Europe, and the Middle East, though its primary office is based in Menlo Park, California.[4] The firm concentrates its investments across several high-growth sectors including blockchain, deep tech, artificial intelligence, healthcare, biotechnology, and pharmaceuticals.[5] Notable portfolio companies include Kraken (a major digital asset exchange), Unnatural Products (an AI-driven drug discovery platform), OneChronos (an AI-powered financial trading exchange), and Twelve (an electrochemistry company converting CO2 into essential products).[2]
Rising Tide was established in 2007 by Ossama Hassanein and Tamer Hassanein, both of whom brought deep entrepreneurial experience to the venture capital space.[3] Rather than approaching investing from a purely analytical distance, the founders had themselves walked the founder's path—launching companies, building teams, and navigating the complexities of scaling businesses.[1] This hands-on background became foundational to the firm's operating philosophy and shaped its commitment to providing mentorship alongside capital.
The firm's evolution reflects a deliberate strategic shift toward identifying market inefficiencies in founder selection. While many venture firms apply standardized criteria that favor conventional founder profiles, Rising Tide recognized that research-backed evidence pointed to superior returns from overlooked co-founder teams. This insight became the cornerstone of their differentiated investment thesis, allowing them to access deal flow and founder talent that competitors systematically undervalued.
Rising Tide distinguishes itself through its commitment to active mentorship and operational support. The firm doesn't simply write checks; partners like Brent MacDonald actively engage with portfolio companies, helping them navigate scaling challenges, expand capabilities, and strengthen ecosystem partnerships.[2] This hands-on approach reflects the founders' own entrepreneurial journeys and creates a meaningful advantage for early-stage companies that benefit from experienced guidance.
The firm's focus on overlooked founders represents a deliberate contrarian bet against conventional venture capital wisdom. By targeting founders and markets that mainstream investors dismiss, Rising Tide accesses superior risk-adjusted returns while simultaneously democratizing access to capital for entrepreneurs outside traditional networks.[1] This approach has proven particularly effective in identifying breakout companies before they become obvious to the broader market.
Rather than concentrating in a single vertical, Rising Tide maintains exposure across blockchain, AI, healthcare, biotechnology, and deep tech—sectors characterized by significant capital requirements and long development timelines.[5] This diversification reduces concentration risk while positioning the firm to benefit from multiple technological megatrends simultaneously. The portfolio spans companies addressing fundamental challenges: drug discovery acceleration, financial market infrastructure modernization, and novel materials science.
The firm's presence across North America, Europe, and the Middle East provides portfolio companies with international expansion pathways and access to diverse talent pools and capital sources.[4] This geographic reach proves particularly valuable for deep tech and biotech companies that often require global supply chains and regulatory expertise.
Rising Tide operates at the intersection of two powerful trends reshaping venture capital: the democratization of founder access and the rise of deep tech as a primary investment thesis. Traditionally, venture capital has concentrated capital among founders with existing networks, prestigious educational backgrounds, or prior startup success—creating a self-reinforcing cycle that excludes talented entrepreneurs from underrepresented geographies and backgrounds.
The firm's contrarian approach challenges this paradigm precisely when market conditions favor it. The venture capital industry has increasingly recognized that founder diversity correlates with innovation and returns, yet most firms lack the operational infrastructure to effectively support non-traditional founders. Rising Tide's hands-on mentorship model fills this gap, particularly for deep tech and biotech founders who require not just capital but strategic guidance through complex regulatory and technical landscapes.
The timing proves particularly significant given the maturation of AI infrastructure, the acceleration of climate tech investment, and the growing institutional acceptance of blockchain technology. Rising Tide's portfolio positioning—with companies like Unnatural Products leveraging machine learning for drug discovery and Twelve applying electrochemistry to carbon utilization—places the firm at the nexus of these transformative trends. By backing overlooked founders pursuing these opportunities, Rising Tide influences the broader ecosystem by demonstrating that innovation often emerges from unexpected sources.
Rising Tide's influence will likely expand as the venture capital industry continues reckoning with the limitations of traditional founder selection criteria. The firm's track record of identifying breakout companies through contrarian founder selection positions it to attract increasingly sophisticated capital from LPs seeking differentiated returns. As deep tech and biotech investments require longer time horizons and more intensive operational support, Rising Tide's hands-on model becomes a competitive advantage rather than a niche positioning.
Looking forward, the firm faces an interesting inflection point. As overlooked founders increasingly become recognized by mainstream venture capital, the firm's edge depends on maintaining its ability to identify the *next* wave of undervalued founder talent before the market catches up. This requires continuous evolution of the firm's sourcing networks and investment thesis. Additionally, as portfolio companies mature and require larger follow-on rounds, Rising Tide's ability to lead or participate in growth-stage investments will determine whether it becomes a full-stack venture platform or remains focused on early-stage discovery.
The broader implication of Rising Tide's approach extends beyond financial returns: by systematically backing overlooked founders, the firm contributes to a more inclusive innovation ecosystem where talent and ideas matter more than pedigree. In an era where technological breakthroughs increasingly determine competitive advantage, this democratization of founder access may prove as valuable to society as it is to Rising Tide's investors.
Key people at Rising Tide.